GINMU >
01 奈良県立医科大学 >
011 医学部 >
0111 学術雑誌論文 >
01111 医学科 >
このアイテムの引用には次の識別子を使用してください:
http://hdl.handle.net/10564/2323
|
|
|
タイトル: | Selective aldosterone blocker ameliorates the progression of non-alcoholic steatohepatitis in rats. |
著者: | Noguchi, Ryuichi Yoshiji, Hitoshi Ikenaka, Yasuhide Kaji, Kosuke Shirai, Yusaku Aihara, Yosuke Yamazaki, Masaharu Namisaki, Tadashi Kitade, Mitsuteru Yoshii, Junichi Yanase, Koji Kawaratani, Hideto Tsujimoto, Tatsuhiro Fukui, Hiroshi |
キーワード: | aldosterone selective aldosterone blocker liver fibrosis hepatocarcinogenesis angiogenesis |
発行日: | 2010年9月 |
出版者: | Spandidos Publications |
引用: | International Journal of Molecular Medicine Vol.26 No.3 pp.407-413 |
抄録: | Although non-alcoholic steatohepatitis (NASH) may progress to cirrhosis and hepatocellular carcinoma (HCC), no effective therapeutic modalities have been fully established yet. Recent studies have shown that the renin-angiotensin-aldosterone-system plays an important role in NASH. The aim of our current study was to elucidate the effects of aldosterone (Ald) inhibition on the progression of NASH. In the choline-deficient L-amino acid-defined diet-induced rat NASH model, the effects of a clinically used selective Ald blocker (SAB) were elucidated in conjunction with the activated hepatic stellate cells (HSC) and neovascularization, which are both known to play important roles in liver fibrosis development and hepatocarcinogenesis, respectively. Liver fibrosis development and the glutathione-S-transferase placental form-positive pre-neoplastic lesions were both markedly attenuated by SAB along with the suppression of the activated HSC and neovascularization. SAB inhibited the hepatic expression of transforming growth factor-β 1 and also that of the vascular endothelial growth factor. Our in vitro study showed that SAB also inhibited the Ald-induced HSC proliferation and in vitro angiogenesis in a dose-dependent manner. These results indicated that Ald plays a pivotal role in the progression of NASH. Considering that SAB is already widely used in clinical practice, this drug could represent a potential new strategy against NASH in the future. |
URI: | http://hdl.handle.net/10564/2323 |
ISSN: | 11073756 |
DOI: | http://dx.doi.org/10.3892/ijmm_00000480 |
出現コレクション: | 01111 医学科
|
このリポジトリに保管されているアイテムは、他に指定されている場合を除き、著作権により保護されています。
|